Indeed, it has been demonstrated that KRAS oncogenic (especially KRASG12V) can induce/up-regulate VEGF in hypoxia via HIF-1-independent mechanisms in colon cancer cells [105]. The gene discussed is HIF1A; the disease is malignant colon neoplasm.